首页 > 最新文献

Journal of Korean Medical Science最新文献

英文 中文
Expert Consensus on Developing Information and Communication Technology-Based Patient Education Guidelines for Rheumatic Diseases in the Korea. 制定基于信息和通信技术的韩国风湿病患者教育指南的专家共识。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-06 DOI: 10.3346/jkms.2025.40.e67
Junghee Yoon, Soo-Kyung Cho, Se Rim Choi, Soo-Bin Lee, Juhee Cho, Chan Hong Jeon, Geun-Tae Kim, Jisoo Lee, Yoon-Kyoung Sung

Background: This study aimed to identify key priorities for the development of guidelines for information and communication technology (ICT)-based patient education tailored to the needs of patients with rheumatic diseases (RDs) in the Republic of Korea, based on expert consensus.

Methods: A two-round modified Delphi study was conducted with 20 rheumatology, patient education, and digital health literacy experts. A total of 35 items covering 7 domains and 18 subdomains were evaluated. Each item was evaluated for its level of importance, and the responses were rated on a 4-point Likert scale. Consensus levels were defined as "high" (interquartile range [IQR] ≤ 1, agreement ≥ 80%, content validity ratio [CVR] ≥ 0.7), "Moderate" (IQR ≥ 1, agreement 50-79%, CVR 0.5-0.7), and "Low" (IQR > 1, agreement < 50%, CVR < 0.5).

Results: Strong consensus was reached for key priorities for developing guidelines in areas such as health literacy, digital health literacy, medical terminology, user interface, and user experience design for mobile apps. Chatbot use and video (e.g., YouTube) also achieved high consensus, whereas AI-powered platforms such as ChatGPT showed moderate-to-high agreement. Telemedicine was excluded because of insufficient consensus.

Conclusion: The key priorities identified in this study provide a foundation for the development of ICT-based patient education guidelines for RDs in the Republic of Korea. Future efforts should focus on integrating digital tools into clinical practice to enhance patient engagement and improve clinical outcomes.

背景:本研究旨在根据专家共识,确定制定基于信息和通信技术(ICT)的患者教育指南的关键优先事项,以适应韩国风湿性疾病(rd)患者的需求。方法:对20名风湿病学、患者教育和数字健康素养专家进行两轮修正德尔菲研究。共评估了35个项目,涵盖7个域和18个子域。每个项目都被评估其重要性的水平,并以4分的李克特量表打分。共识水平定义为“高”(四分位数间距[IQR]≤1,一致性≥80%,内容效度[CVR]≥0.7),“中等”(IQR≥1,一致性50-79%,CVR 0.5-0.7)和“低”(IQR > 1,一致性< 50%,CVR < 0.5)。结果:就制定卫生素养、数字卫生素养、医学术语、用户界面和移动应用程序用户体验设计等领域指导方针的关键优先事项达成了强烈共识。聊天机器人的使用和视频(如YouTube)也取得了很高的共识,而ChatGPT等人工智能平台则表现出中高的一致性。由于共识不足,远程医疗被排除在外。结论:本研究确定的关键优先事项为制定韩国基于信息通信技术的rd患者教育指南奠定了基础。未来的努力应侧重于将数字工具整合到临床实践中,以提高患者参与度并改善临床结果。
{"title":"Expert Consensus on Developing Information and Communication Technology-Based Patient Education Guidelines for Rheumatic Diseases in the Korea.","authors":"Junghee Yoon, Soo-Kyung Cho, Se Rim Choi, Soo-Bin Lee, Juhee Cho, Chan Hong Jeon, Geun-Tae Kim, Jisoo Lee, Yoon-Kyoung Sung","doi":"10.3346/jkms.2025.40.e67","DOIUrl":"https://doi.org/10.3346/jkms.2025.40.e67","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to identify key priorities for the development of guidelines for information and communication technology (ICT)-based patient education tailored to the needs of patients with rheumatic diseases (RDs) in the Republic of Korea, based on expert consensus.</p><p><strong>Methods: </strong>A two-round modified Delphi study was conducted with 20 rheumatology, patient education, and digital health literacy experts. A total of 35 items covering 7 domains and 18 subdomains were evaluated. Each item was evaluated for its level of importance, and the responses were rated on a 4-point Likert scale. Consensus levels were defined as \"high\" (interquartile range [IQR] ≤ 1, agreement ≥ 80%, content validity ratio [CVR] ≥ 0.7), \"Moderate\" (IQR ≥ 1, agreement 50-79%, CVR 0.5-0.7), and \"Low\" (IQR > 1, agreement < 50%, CVR < 0.5).</p><p><strong>Results: </strong>Strong consensus was reached for key priorities for developing guidelines in areas such as health literacy, digital health literacy, medical terminology, user interface, and user experience design for mobile apps. Chatbot use and video (e.g., YouTube) also achieved high consensus, whereas AI-powered platforms such as ChatGPT showed moderate-to-high agreement. Telemedicine was excluded because of insufficient consensus.</p><p><strong>Conclusion: </strong>The key priorities identified in this study provide a foundation for the development of ICT-based patient education guidelines for RDs in the Republic of Korea. Future efforts should focus on integrating digital tools into clinical practice to enhance patient engagement and improve clinical outcomes.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 1","pages":"e67"},"PeriodicalIF":3.0,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707660/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142950248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender Difference of Moderated Mediating Effect of Grit Between Occupational Stress and Suicidal Ideation in Korean Workers. 韩国工人职业压力对自杀意念的调节作用的性别差异。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-12-30 DOI: 10.3346/jkms.2024.39.e308
Sra Jung, Hyejeong Jeon, Mi Yeon Lee, Eunsoo Kim, Dong-Won Shin, Young-Chul Shin, Kang-Seob Oh, Min-Kyoung Kim, Sang-Won Jeon, Sung Joon Cho

Background: This study examined gender differences in occupational stress, depressive symptoms, and suicidal ideation by considering the potential moderating effect of grit on Korean employees.

Methods: A total of 11,369 participants (7,735 men and 3,634 women) aged 19-65 years, employed across 18 private companies and local government organizations in Korea, completed questionnaires including the Short Grit Scale, Korean Occupational Stress Scale, and Center for Epidemiologic Studies Depression Scale between April 2020 and March 2022. Suicidal ideation was assessed based on its presence or absence. Mediation and moderation analyses were performed using the Statistical Package for the Social Sciences PROCESS macro.

Results: Depressive symptoms partially mediated the relationship between occupational stress and suicidal ideation in male employees, whereas depressive symptoms fully mediated the relationship in female employees. Grit moderated the relationship between depressive symptoms and suicidal ideation in male employees but not in female employees. Furthermore, the moderated mediating effect of grit in male employees on the relationship between occupational stress and suicidal ideation provided less protection in cases of severe depression. The cross-sectional design does not allow for causal inferences.

Conclusion: These findings contribute to understanding of the gender differences in the impact of depressive symptoms on the relationship between occupational stress and suicidal ideation, as well as the protective effect of grit. These findings highlight the need for gender-specific approaches to prevent suicidal ideation among employees.

背景:本研究考察了韩国员工在职业压力、抑郁症状和自杀意念方面的性别差异,并考虑了毅力的潜在调节作用。方法:在2020年4月至2022年3月期间,共有11369名参与者(7735名男性和3634名女性),年龄在19-65岁之间,受雇于韩国18家私营公司和地方政府机构,完成了包括短沙砾量表、韩国职业压力量表和流行病学研究中心抑郁量表在内的问卷调查。根据是否存在自杀意念进行评估。使用社会科学过程宏观统计软件包进行中介和调节分析。结果:抑郁症状在男性员工职业压力与自杀意念的关系中起部分中介作用,在女性员工职业压力与自杀意念的关系中起完全中介作用。勇气调节了男性员工抑郁症状与自杀意念的关系,但对女性员工没有调节作用。此外,男性员工意志力在职业压力与自杀意念之间的中介作用在严重抑郁情况下的保护作用较弱。横断面设计不允许因果推论。结论:这些研究结果有助于理解抑郁症状对职业压力与自杀意念关系影响的性别差异,以及沙砾的保护作用。这些发现强调了采取针对不同性别的方法来防止员工产生自杀意念的必要性。
{"title":"Gender Difference of Moderated Mediating Effect of Grit Between Occupational Stress and Suicidal Ideation in Korean Workers.","authors":"Sra Jung, Hyejeong Jeon, Mi Yeon Lee, Eunsoo Kim, Dong-Won Shin, Young-Chul Shin, Kang-Seob Oh, Min-Kyoung Kim, Sang-Won Jeon, Sung Joon Cho","doi":"10.3346/jkms.2024.39.e308","DOIUrl":"10.3346/jkms.2024.39.e308","url":null,"abstract":"<p><strong>Background: </strong>This study examined gender differences in occupational stress, depressive symptoms, and suicidal ideation by considering the potential moderating effect of grit on Korean employees.</p><p><strong>Methods: </strong>A total of 11,369 participants (7,735 men and 3,634 women) aged 19-65 years, employed across 18 private companies and local government organizations in Korea, completed questionnaires including the Short Grit Scale, Korean Occupational Stress Scale, and Center for Epidemiologic Studies Depression Scale between April 2020 and March 2022. Suicidal ideation was assessed based on its presence or absence. Mediation and moderation analyses were performed using the Statistical Package for the Social Sciences PROCESS macro.</p><p><strong>Results: </strong>Depressive symptoms partially mediated the relationship between occupational stress and suicidal ideation in male employees, whereas depressive symptoms fully mediated the relationship in female employees. Grit moderated the relationship between depressive symptoms and suicidal ideation in male employees but not in female employees. Furthermore, the moderated mediating effect of grit in male employees on the relationship between occupational stress and suicidal ideation provided less protection in cases of severe depression. The cross-sectional design does not allow for causal inferences.</p><p><strong>Conclusion: </strong>These findings contribute to understanding of the gender differences in the impact of depressive symptoms on the relationship between occupational stress and suicidal ideation, as well as the protective effect of grit. These findings highlight the need for gender-specific approaches to prevent suicidal ideation among employees.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 50","pages":"e308"},"PeriodicalIF":3.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685280/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concise Recommendations for EDitorials: Enhancing Narratives and Composition Effectively (CREDENCE). 对社论的简明建议:有效地增强叙述和构图(CREDENCE)。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-12-30 DOI: 10.3346/jkms.2024.39.e338
Ilke Coskun Benlidayi, Latika Gupta

An editorial article is a type of scholarly communication providing expert views and critical analysis of issues. It may reflect the view of the author(s) or of the organization/journal on a certain topic. An editorial may also comment on a published paper. Editorials are expected to be objective, evidence-based, and informative focusing attention on recent developments and matters of current societal/disciplinary concern. This format allows for timely dissemination of expert insight and facilitates ongoing scholarly discourse. The structure of editorials varies: critical, explanatory, and commendatory types serve varied purposes. Authors of editorials should follow certain principles of academic writing. The aim should be provided in an introductory paragraph. Thereafter, a constructive and balanced critique of the index article and/or a detailed yet concise analyze of the subject of matter should be provided. The conclusion paragraph should include brief take-home messages. Critical arguing should be supported by relevant references. A declaration of any potential conflicts of interests is essential to maintain objectivity and fairness. The current article aims to provide a primer, along with a checklist, on writing editorials.

社论文章是一种学术传播,提供专家观点和对问题的批判性分析。它可能反映了作者或组织/期刊对某个主题的看法。社论也可以评论已发表的论文。社论应该是客观的、基于证据的、翔实的,关注最近的发展和当前社会/学科关注的问题。这种形式允许及时传播专家的见解,并促进正在进行的学术论述。社论的结构各不相同:批评的、解释的和褒义的类型服务于不同的目的。社论的作者应该遵循一定的学术写作原则。目的应在导言段落中说明。此后,应对索引文章进行建设性和平衡的批评和/或对该主题进行详细而简洁的分析。结论段应该包含简短的关键信息。批判性的论点应该有相关的参考文献支持。任何潜在利益冲突的声明对于保持客观性和公正性至关重要。本文的目的是为撰写社论提供一个基础知识,以及一个清单。
{"title":"Concise Recommendations for EDitorials: Enhancing Narratives and Composition Effectively (CREDENCE).","authors":"Ilke Coskun Benlidayi, Latika Gupta","doi":"10.3346/jkms.2024.39.e338","DOIUrl":"10.3346/jkms.2024.39.e338","url":null,"abstract":"<p><p>An editorial article is a type of scholarly communication providing expert views and critical analysis of issues. It may reflect the view of the author(s) or of the organization/journal on a certain topic. An editorial may also comment on a published paper. Editorials are expected to be objective, evidence-based, and informative focusing attention on recent developments and matters of current societal/disciplinary concern. This format allows for timely dissemination of expert insight and facilitates ongoing scholarly discourse. The structure of editorials varies: critical, explanatory, and commendatory types serve varied purposes. Authors of editorials should follow certain principles of academic writing. The aim should be provided in an introductory paragraph. Thereafter, a constructive and balanced critique of the index article and/or a detailed yet concise analyze of the subject of matter should be provided. The conclusion paragraph should include brief take-home messages. Critical arguing should be supported by relevant references. A declaration of any potential conflicts of interests is essential to maintain objectivity and fairness. The current article aims to provide a primer, along with a checklist, on writing editorials.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 50","pages":"e338"},"PeriodicalIF":3.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685276/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In This Issue on 30-December-2024. 刊登于2024年12月30日
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-12-30 DOI: 10.3346/jkms.2024.39.e337
Jin-Hong Yoo
{"title":"In This Issue on 30-December-2024.","authors":"Jin-Hong Yoo","doi":"10.3346/jkms.2024.39.e337","DOIUrl":"10.3346/jkms.2024.39.e337","url":null,"abstract":"","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 50","pages":"e337"},"PeriodicalIF":3.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685278/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Value of Retinoblastoma in Small Intestinal Adenocarcinoma: A Multicenter Retrospective Study. 小肠腺癌视网膜母细胞瘤的预后价值:一项多中心回顾性研究。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-12-30 DOI: 10.3346/jkms.2024.39.e335
Sun-Young Jun, Seung-Mo Hong, Kee-Taek Jang

Background: The retinoblastoma (RB) protein which is encoded by RB gene selectively provides a cell type-specific function in malignancies. In colorectal carcinoma, RB has been highly expressed and related cyclin/cyclin-dependent kinase 4/6 inhibitors have shown improved therapeutic effects in some patients. However, little is known about RB in small intestinal adenocarcinoma (SIAC).

Methods: Here, we conducted a multi-institutional study of RB expression in 229 surgically resected SIACs to explore the clinicopathologic and prognostic implications and the relationship with microsatellite instability (MSI) status and KRAS mutations.

Results: High RB expression (RBHigh) was more commonly observed in SIACs (76/229, 33%) than in normal small intestinal mucosa (27/188, 14%; P < 0.001). RBHigh was associated with nodular growth patterns (P = 0.028), the absence of lymphovascular (P = 0.001) and perineural invasion (P = 0.048), and a lower T category (P = 0.042) and indicated better overall survival (P = 0.003). In multivariate analysis, RBHigh (P = 0.049) was an independent prognostic predictor of better prognosis, along with younger patient age (P = 0.049), the absence of retroperitoneal seeding (P = 0.004), lower tumor stage (P < 0.001), and MSI (P = 0.005). The prognostic impact of RB expression was consistently observed regardless of MSI status and specifically persistent in SIACs with lower stages (stages I and II).

Conclusion: RBHigh was related to favorable clinicopathologic SIAC characteristics and indicated better patient prognosis. The prognostic predictability of RB was found in SIACs with lower stages, independent of MSI status. RB expression is a reliable and potent prognostic indicator for SIAC and may aid in selecting chemotherapy for patients.

背景:由RB基因编码的视网膜母细胞瘤(retinoblastoma, RB)蛋白在恶性肿瘤中具有选择性的细胞特异性功能。在结直肠癌中,RB已经高表达,相关的细胞周期蛋白/细胞周期蛋白依赖性激酶4/6抑制剂在一些患者中显示出改善的治疗效果。然而,RB在小肠腺癌(SIAC)中的作用尚不清楚。方法:我们在229例手术切除的SIACs中进行了多机构RB表达研究,以探讨其临床病理和预后意义以及与微卫星不稳定性(MSI)状态和KRAS突变的关系。结果:RB高表达(RBHigh)在siac中较在正常小肠黏膜中更为常见(76/229,33%)(27/188,14%;P < 0.001)。RBHigh与结节生长模式(P = 0.028)、淋巴血管缺失(P = 0.001)和神经周围浸润(P = 0.048)以及较低的T分类(P = 0.042)相关,并表明更好的总生存率(P = 0.003)。在多因素分析中,RBHigh (P = 0.049)与患者年龄较小(P = 0.049)、腹膜后播种缺失(P = 0.004)、肿瘤分期较低(P < 0.001)和MSI (P = 0.005)是预后较好的独立预测因子。无论MSI状态如何,RB表达对预后的影响都是一致的,特别是在SIAC较低分期(I期和II期)中持续存在。结论:RBHigh与有利的SIAC临床病理特征相关,预示着更好的患者预后。在较低分期的siac中发现RB的预后可预测性,与MSI状态无关。RB表达是SIAC的可靠和有效的预后指标,可能有助于患者选择化疗方案。
{"title":"Prognostic Value of Retinoblastoma in Small Intestinal Adenocarcinoma: A Multicenter Retrospective Study.","authors":"Sun-Young Jun, Seung-Mo Hong, Kee-Taek Jang","doi":"10.3346/jkms.2024.39.e335","DOIUrl":"10.3346/jkms.2024.39.e335","url":null,"abstract":"<p><strong>Background: </strong>The retinoblastoma (RB) protein which is encoded by <i>RB</i> gene selectively provides a cell type-specific function in malignancies. In colorectal carcinoma, RB has been highly expressed and related cyclin/cyclin-dependent kinase 4/6 inhibitors have shown improved therapeutic effects in some patients. However, little is known about RB in small intestinal adenocarcinoma (SIAC).</p><p><strong>Methods: </strong>Here, we conducted a multi-institutional study of RB expression in 229 surgically resected SIACs to explore the clinicopathologic and prognostic implications and the relationship with microsatellite instability (MSI) status and <i>KRAS</i> mutations.</p><p><strong>Results: </strong>High RB expression (RB<sup>High</sup>) was more commonly observed in SIACs (76/229, 33%) than in normal small intestinal mucosa (27/188, 14%; <i>P</i> < 0.001). RB<sup>High</sup> was associated with nodular growth patterns (<i>P</i> = 0.028), the absence of lymphovascular (<i>P</i> = 0.001) and perineural invasion (<i>P</i> = 0.048), and a lower T category (<i>P</i> = 0.042) and indicated better overall survival (<i>P</i> = 0.003). In multivariate analysis, RB<sup>High</sup> (<i>P</i> = 0.049) was an independent prognostic predictor of better prognosis, along with younger patient age (<i>P</i> = 0.049), the absence of retroperitoneal seeding (<i>P</i> = 0.004), lower tumor stage (<i>P</i> < 0.001), and MSI (<i>P</i> = 0.005). The prognostic impact of RB expression was consistently observed regardless of MSI status and specifically persistent in SIACs with lower stages (stages I and II).</p><p><strong>Conclusion: </strong>RB<sup>High</sup> was related to favorable clinicopathologic SIAC characteristics and indicated better patient prognosis. The prognostic predictability of RB was found in SIACs with lower stages, independent of MSI status. RB expression is a reliable and potent prognostic indicator for SIAC and may aid in selecting chemotherapy for patients.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 50","pages":"e335"},"PeriodicalIF":3.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cesarean Delivery Upon Request in Pregnancies Following Vaginal Delivery: A Nationwide Study. 阴道分娩后妊娠要求剖宫产:一项全国性研究。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-12-30 DOI: 10.3346/jkms.2024.39.e318
Young Mi Jung, Wonyoung Wi, Kyu-Dong Cho, Su Jung Hong, Min-Jeong Oh, Geum Joon Cho, Joong Shin Park
<p><strong>Background: </strong>The increasing rate of cesarean delivery (CD) is a significant concern in many societies worldwide. Vaginal delivery (VD) is preferred over CD for subsequent pregnancies after successful VD, for women with no specific obstetrical indications, primarily because of concerns about potential complications arising from the surgical procedure. However, the factors that influence the decision of requesting a CD have not yet been thoroughly investigated. This study aimed to examine the underlying reasons that lead mothers to choose CDs in subsequent pregnancies following a VD.</p><p><strong>Methods: </strong>This retrospective study included women who underwent VD in their first pregnancy between 2011 and 2020 and had a second pregnancy and childbirth within the study period. The analysis focused on women eligible for a trial of labor (TOL) in their second pregnancy, excluding those with conditions necessitating a CD. The study defined two groups: the TOL in second pregnancy (TOLS) group, consisting of women with one previous VD who attempted a VD in their subsequent pregnancy; and the CD on maternal request in second pregnancy (CDRS) group, comprising women with one past VD who opted for a CD in their second pregnancy without medical indication. The TOLS and CDRS groups were compared regarding obstetric and neonatal outcomes.</p><p><strong>Results: </strong>During the study period, 372,749 women met the inclusion criteria: 368,311 women in TOLS group and 4,438 women in CDRS group. In the regression analysis for the CDRS, several factors were identified as increasing the risk of choosing CD, including age (adjusted odds ratio [aOR], 1.06; 95% confidence interval [CI], 1.05-1.07), interval between the first and second pregnancies (aOR, 1.32; 95% CI 1.29-1.35), a history of pre-existing hypertension (aOR, 1.76; 95% CI, 1.17-2.65), gestational diabetes mellitus (GDM) during the first pregnancy (aOR, 1.19; 95% CI, 1.05-1.36), hypertensive disease during pregnancy (HDP) (aOR, 1.33; 95% CI, 1.06-1.67), preterm labor during the first pregnancy (aOR, 1.57; 95% CI, 1.32-1.86), postpartum hemorrhage (aOR, 1.33; 95% CI, 1.21-1.47), traumatic event during delivery (aOR, 1.19; 95% CI, 1.12-1.28), surgical VD (aOR, 1.29; 95% CI, 1.19-1.40), and pregnancies with abortive outcomes between the first and second pregnancies (aOR, 1.18; 95% CI, 1.08-1.29). Additionally, women with pre-existing diabetes (aOR, 1.53; 95% CI, 1.24-1.89), pre-existing hypertension (aOR, 1.69; 95% CI, 1.26-2.26), GDM (aOR, 1.23; 95% CI, 1.11-1.37), or HDP (aOR, 2.57; 95% CI, 2.24-2.94) during the second pregnancy continued to exhibit an increased risk of opting for CD even after adjustment.</p><p><strong>Conclusion: </strong>CD after VD was more prevalent among women with certain demographic characteristics and obstetric histories. Investigating the factors influencing women to request CD can be helpful in making informed decisions about safe delivery methods and m
背景:剖宫产率的上升是全世界许多社会关注的一个重要问题。对于没有特定产科指征的妇女,阴道分娩(VD)比CD更适合于VD成功后的后续妊娠,主要是因为担心手术过程中可能出现的并发症。但是,尚未对影响是否要求提供光盘的决定的因素进行彻底调查。本研究旨在探讨导致母亲在患VD后的妊娠中选择cd的潜在原因。方法:这项回顾性研究纳入了2011年至2020年间首次怀孕并在研究期间第二次怀孕和分娩的女性。分析的重点是有资格在第二次怀孕时进行分娩试验(TOL)的妇女,不包括那些需要CD的妇女。研究定义了两组:第二次怀孕时的TOL组,由先前患有VD的妇女组成,她们在随后的怀孕中尝试过VD;第二次妊娠中母亲要求的乳糜泻组(CDRS),包括有过一次VD的妇女,在没有医学指征的情况下在第二次妊娠中选择了乳糜泻。比较TOLS组和CDRS组的产科和新生儿结局。结果:在研究期间,372,749例妇女符合纳入标准:TOLS组368,311例,CDRS组4,438例。在CDRS的回归分析中,几个因素被确定为增加选择CD的风险,包括年龄(调整后的优势比[aOR], 1.06;95%可信区间[CI], 1.05-1.07),第一次和第二次怀孕之间的间隔(aOR, 1.32;95% CI 1.29-1.35),既往高血压史(aOR, 1.76;95% CI, 1.17-2.65),妊娠期糖尿病(GDM) (aOR, 1.19;95% CI, 1.05-1.36),妊娠期高血压疾病(HDP) (aOR, 1.33;95% CI, 1.06-1.67),首次妊娠早产(aOR, 1.57;95% CI, 1.32-1.86),产后出血(aOR, 1.33;95% CI, 1.21-1.47),分娩时创伤性事件(aOR, 1.19;95% CI, 1.12-1.28),手术VD (aOR, 1.29;95% CI, 1.19-1.40),以及第一次和第二次妊娠之间有流产结局的妊娠(aOR, 1.18;95% ci, 1.08-1.29)。此外,已有糖尿病的女性(aOR, 1.53;95% CI, 1.24-1.89),既往高血压(aOR, 1.69;95% CI, 1.26-2.26), GDM (aOR, 1.23;95% CI, 1.11-1.37)或HDP (aOR, 2.57;95% CI, 2.24-2.94)在第二次怀孕期间,即使在调整后,选择CD的风险仍然增加。结论:VD后CD在具有一定人口统计学特征和产科史的女性中更为普遍。调查影响妇女要求乳糜泻的因素有助于对安全分娩方法作出明智的决定,也可能影响乳糜泻率。
{"title":"Cesarean Delivery Upon Request in Pregnancies Following Vaginal Delivery: A Nationwide Study.","authors":"Young Mi Jung, Wonyoung Wi, Kyu-Dong Cho, Su Jung Hong, Min-Jeong Oh, Geum Joon Cho, Joong Shin Park","doi":"10.3346/jkms.2024.39.e318","DOIUrl":"10.3346/jkms.2024.39.e318","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The increasing rate of cesarean delivery (CD) is a significant concern in many societies worldwide. Vaginal delivery (VD) is preferred over CD for subsequent pregnancies after successful VD, for women with no specific obstetrical indications, primarily because of concerns about potential complications arising from the surgical procedure. However, the factors that influence the decision of requesting a CD have not yet been thoroughly investigated. This study aimed to examine the underlying reasons that lead mothers to choose CDs in subsequent pregnancies following a VD.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This retrospective study included women who underwent VD in their first pregnancy between 2011 and 2020 and had a second pregnancy and childbirth within the study period. The analysis focused on women eligible for a trial of labor (TOL) in their second pregnancy, excluding those with conditions necessitating a CD. The study defined two groups: the TOL in second pregnancy (TOLS) group, consisting of women with one previous VD who attempted a VD in their subsequent pregnancy; and the CD on maternal request in second pregnancy (CDRS) group, comprising women with one past VD who opted for a CD in their second pregnancy without medical indication. The TOLS and CDRS groups were compared regarding obstetric and neonatal outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;During the study period, 372,749 women met the inclusion criteria: 368,311 women in TOLS group and 4,438 women in CDRS group. In the regression analysis for the CDRS, several factors were identified as increasing the risk of choosing CD, including age (adjusted odds ratio [aOR], 1.06; 95% confidence interval [CI], 1.05-1.07), interval between the first and second pregnancies (aOR, 1.32; 95% CI 1.29-1.35), a history of pre-existing hypertension (aOR, 1.76; 95% CI, 1.17-2.65), gestational diabetes mellitus (GDM) during the first pregnancy (aOR, 1.19; 95% CI, 1.05-1.36), hypertensive disease during pregnancy (HDP) (aOR, 1.33; 95% CI, 1.06-1.67), preterm labor during the first pregnancy (aOR, 1.57; 95% CI, 1.32-1.86), postpartum hemorrhage (aOR, 1.33; 95% CI, 1.21-1.47), traumatic event during delivery (aOR, 1.19; 95% CI, 1.12-1.28), surgical VD (aOR, 1.29; 95% CI, 1.19-1.40), and pregnancies with abortive outcomes between the first and second pregnancies (aOR, 1.18; 95% CI, 1.08-1.29). Additionally, women with pre-existing diabetes (aOR, 1.53; 95% CI, 1.24-1.89), pre-existing hypertension (aOR, 1.69; 95% CI, 1.26-2.26), GDM (aOR, 1.23; 95% CI, 1.11-1.37), or HDP (aOR, 2.57; 95% CI, 2.24-2.94) during the second pregnancy continued to exhibit an increased risk of opting for CD even after adjustment.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;CD after VD was more prevalent among women with certain demographic characteristics and obstetric histories. Investigating the factors influencing women to request CD can be helpful in making informed decisions about safe delivery methods and m","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 50","pages":"e318"},"PeriodicalIF":3.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Genetic Testing in Diagnosis and Prognosis Prediction in Hypertrophic Cardiomyopathy in Korea. 基因检测在韩国肥厚性心肌病诊断和预后预测中的作用。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-12-30 DOI: 10.3346/jkms.2024.39.e313
Seo-Yeon Gwak, Jiwon Seo, Go Hun Seo, Jiyoung Oh, Hyun-Jung Lee, Kyu Kim, Iksung Cho, Chi Young Shim, Jong-Won Ha, Geu-Ru Hong

Background: Hypertrophic cardiomyopathy (HCM) needs careful differentiation from other cardiomyopathies. Current guidelines recommend genetic testing, but genetic data on differential diagnoses and their relation with clinical outcomes in HCM are still lacking. This study aimed to investigate the prevalence of genetic variants and the proportion of other cardiomyopathies in patients with suspected HCM in Korea and compare the outcomes of HCM according to the presence of sarcomere gene mutation.

Methods: We enrolled 1,554 patients with suspected HCM having left ventricular hypertrophy on transthoracic echocardiography between April 2012 and February 2023. Patients who declined genetic testing or who had pure apical HCM without a familial history were excluded. Genetic testing was performed using a next-generation sequencing panel or whole-exome sequencing for cardiomyopathies. We performed cardiovascular magnetic resonance if the diagnosis was inconclusive. Genotype-positive HCM was defined as sarcomere gene mutations of pathogenic or likely pathogenic variants. Adverse clinical outcomes were defined as a composite of all-cause death, resuscitated cardiac arrest, heart failure-related admission, appropriate implantable cardioverter defibrillator shocks, and stroke.

Results: Of 492 patients (mean age 49.6 ± 14.7 years, 29.4% women) who underwent genetic testing, 214 (43.5%) had disease-causing gene mutations. After combining gene tests, multi-imaging modality, and clinical information, 447 (90.9%) had HCM, and 27 (5.5%) had Fabry disease. Among the HCM patients, 182 (40.7%) were genotype-positive, and 265 (59.3%) were genotype-negative. Kaplan-Meier curve analysis showed that genotype-positive HCM patients experienced more composite outcomes (log-rank, P < 0.001). In multivariable Cox analysis, non-sustained ventricular tachycardia (NSVT) (hazard ratio [HR], 1.91; 95% confidence interval [CI], 1.17-3.12; P = 0.010), left ventricular ejection fraction (LVEF) < 50% (HR, 5.50; 95% CI, 2.68-11.27; P < 0.001), LA reservoir strain (HR, 0.96; 95% CI, 0.93-0.99; P = 0.037), and positive sarcomere gene mutation (HR, 1.70; 95% CI, 1.04-2.78; P = 0.034) were significantly association with composite outcomes. Sarcomere gene mutation had incremental value for predicting adverse outcomes added on NSVT and LVEF < 50%.

Conclusion: Genetic testing is helpful in diagnosing HCM, and sarcomere gene mutations in HCM are significantly associated with clinical outcomes.

背景:肥厚性心肌病(HCM)需要与其他心肌病仔细鉴别。目前的指南推荐基因检测,但HCM鉴别诊断的基因数据及其与临床结果的关系仍然缺乏。本研究旨在调查韩国疑似HCM患者遗传变异的患病率和其他心肌病的比例,并根据肌瘤基因突变的存在比较HCM的预后。方法:2012年4月至2023年2月,我们招募了1554例经胸超声心动图检查的疑似HCM左室肥厚患者。拒绝基因检测或无家族病史的纯根尖HCM患者被排除在外。使用下一代测序面板或全外显子组测序进行心肌病基因检测。如果诊断不确定,我们进行心血管磁共振。基因型阳性HCM定义为肌瘤基因突变的致病性或可能致病性变异。不良临床结果定义为全因死亡、复苏的心脏骤停、心力衰竭相关入院、适当的植入式心律转复除颤器电击和中风。结果:在接受基因检测的492例患者(平均年龄49.6±14.7岁,29.4%为女性)中,214例(43.5%)存在致病基因突变。综合基因检测、多种影像学检查及临床资料,HCM 447例(90.9%),法布里病27例(5.5%)。HCM患者中基因型阳性182例(40.7%),基因型阴性265例(59.3%)。Kaplan-Meier曲线分析显示基因型阳性的HCM患者有更多的综合结局(log-rank, P < 0.001)。在多变量Cox分析中,非持续性室性心动过速(NSVT)(风险比[HR], 1.91;95%置信区间[CI], 1.17-3.12;P = 0.010),左室射血分数(LVEF) < 50% (HR, 5.50;95% ci, 2.68-11.27;P < 0.001), LA水库菌株(HR, 0.96;95% ci, 0.93-0.99;P = 0.037),肌节基因突变阳性(HR, 1.70;95% ci, 1.04-2.78;P = 0.034)与综合结果显著相关。在非svt和LVEF < 50%时,肌瘤基因突变对不良预后的预测价值增加。结论:基因检测有助于HCM的诊断,HCM中肌瘤基因突变与临床预后有显著相关性。
{"title":"Role of Genetic Testing in Diagnosis and Prognosis Prediction in Hypertrophic Cardiomyopathy in Korea.","authors":"Seo-Yeon Gwak, Jiwon Seo, Go Hun Seo, Jiyoung Oh, Hyun-Jung Lee, Kyu Kim, Iksung Cho, Chi Young Shim, Jong-Won Ha, Geu-Ru Hong","doi":"10.3346/jkms.2024.39.e313","DOIUrl":"10.3346/jkms.2024.39.e313","url":null,"abstract":"<p><strong>Background: </strong>Hypertrophic cardiomyopathy (HCM) needs careful differentiation from other cardiomyopathies. Current guidelines recommend genetic testing, but genetic data on differential diagnoses and their relation with clinical outcomes in HCM are still lacking. This study aimed to investigate the prevalence of genetic variants and the proportion of other cardiomyopathies in patients with suspected HCM in Korea and compare the outcomes of HCM according to the presence of sarcomere gene mutation.</p><p><strong>Methods: </strong>We enrolled 1,554 patients with suspected HCM having left ventricular hypertrophy on transthoracic echocardiography between April 2012 and February 2023. Patients who declined genetic testing or who had pure apical HCM without a familial history were excluded. Genetic testing was performed using a next-generation sequencing panel or whole-exome sequencing for cardiomyopathies. We performed cardiovascular magnetic resonance if the diagnosis was inconclusive. Genotype-positive HCM was defined as sarcomere gene mutations of pathogenic or likely pathogenic variants. Adverse clinical outcomes were defined as a composite of all-cause death, resuscitated cardiac arrest, heart failure-related admission, appropriate implantable cardioverter defibrillator shocks, and stroke.</p><p><strong>Results: </strong>Of 492 patients (mean age 49.6 ± 14.7 years, 29.4% women) who underwent genetic testing, 214 (43.5%) had disease-causing gene mutations. After combining gene tests, multi-imaging modality, and clinical information, 447 (90.9%) had HCM, and 27 (5.5%) had Fabry disease. Among the HCM patients, 182 (40.7%) were genotype-positive, and 265 (59.3%) were genotype-negative. Kaplan-Meier curve analysis showed that genotype-positive HCM patients experienced more composite outcomes (log-rank, <i>P</i> < 0.001). In multivariable Cox analysis, non-sustained ventricular tachycardia (NSVT) (hazard ratio [HR], 1.91; 95% confidence interval [CI], 1.17-3.12; <i>P</i> = 0.010), left ventricular ejection fraction (LVEF) < 50% (HR, 5.50; 95% CI, 2.68-11.27; <i>P</i> < 0.001), LA reservoir strain (HR, 0.96; 95% CI, 0.93-0.99; <i>P</i> = 0.037), and positive sarcomere gene mutation (HR, 1.70; 95% CI, 1.04-2.78; <i>P</i> = 0.034) were significantly association with composite outcomes. Sarcomere gene mutation had incremental value for predicting adverse outcomes added on NSVT and LVEF < 50%.</p><p><strong>Conclusion: </strong>Genetic testing is helpful in diagnosing HCM, and sarcomere gene mutations in HCM are significantly associated with clinical outcomes.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 50","pages":"e313"},"PeriodicalIF":3.0,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685281/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological Characteristics and Outcome of Myocarditis and Pericarditis Temporally Associated With BNT162b2 COVID-19 Vaccine in Adolescents: Korean National Surveillance. 与BNT162b2 COVID-19疫苗相关的青少年心肌炎和心包炎的流行病学特征和结局:韩国国家监测
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-12-23 DOI: 10.3346/jkms.2024.39.e317
Bin Ahn, Seung Hwan Shin, Myung-Jae Hwang, HyoSug Choi, Sara Na, Sangshin Park, Jue Seong Lee, Young June Choe, Yoonsun Yoon, Kyoungsan Seo, Jong Hee Kim, Hyun Mi Kang

Background: This study aimed to investigate the epidemiological characteristics and outcomes of myocarditis/pericarditis after BNT162b2 vaccination in Korean adolescents.

Methods: This was a retrospective cohort analysis of adolescents aged 12-19 years old diagnosed with myocarditis/pericarditis within 42 days of BNT162b2 mRNA vaccination. All reported cases were investigated by city or government epidemiologists and the diagnostic certainty and causality was determined by the Korea Disease Control and Prevention Agency's Adverse Event Following Immunization Expert Advisory Committee according to the modified version of Brighton Collaboration Myocarditis/Pericarditis Working group's case definitions.

Results: A total 3,709,063 adolescents aged 12-19 received 8,135,240 doses of the BNT162b2 vaccine in South Korea, and 184 cases met the Brighton criteria for the case definition of myocarditis and pericarditis with diagnostic certainty of possible and above. The median age was 17 years old (interquartile range [IQR], 15-18) and boys accounted for 81.5% (n = 150/184) of the cases. The overall incidence was 2.25 (95% confidence interval [CI], 1.94-2.60) cases per 100,000 doses and severe cases was 0.25 (95% CI, 0.15-3.80) cases per 100,000 doses. The highest incidence rate was observed in boys after the second dose, with 5.01 (95% CI, 4.12-6.17) cases per 100,000 doses. A total 89.1% (164/184) were classified as mild, and no deaths were reported.

Conclusion: The highest incidence of myocarditis/pericarditis after BNT162b2 immunization was observed in male adolescents after the second dose, with majority of the cases presenting with a mild clinical course and favorable outcome.

背景:本研究旨在调查韩国青少年接种BNT162b2疫苗后心肌炎/心包炎的流行病学特征和结局。方法:对接种BNT162b2 mRNA疫苗42天内诊断为心肌炎/心包炎的12-19岁青少年进行回顾性队列分析。所有报告的病例均由城市或政府流行病学家调查,诊断的确定性和因果关系由韩国疾病预防控制院免疫接种后不良事件专家咨询委员会根据布莱顿合作心肌炎/心包炎工作组病例定义的修改版本确定。结果:韩国共有3,709,063名12-19岁青少年接种了8,135,240剂BNT162b2疫苗,184例符合心肌炎和心包炎病例定义的布莱顿标准,诊断确定性在可能及以上。中位年龄为17岁(四分位间距[IQR], 15-18岁),男孩占81.5% (n = 150/184)。总发病率为每10万剂量2.25例(95%可信区间[CI], 1.94-2.60),重症病例为每10万剂量0.25例(95% CI, 0.15-3.80)。在第二次注射后,男孩的发病率最高,为5.01 (95% CI, 4.12-6.17) / 10万剂。共有89.1%(164/184)为轻度,无死亡报告。结论:第二次接种BNT162b2疫苗后,男性青少年心肌炎/心包炎发病率最高,多数病例临床病程轻,预后良好。
{"title":"Epidemiological Characteristics and Outcome of Myocarditis and Pericarditis Temporally Associated With BNT162b2 COVID-19 Vaccine in Adolescents: Korean National Surveillance.","authors":"Bin Ahn, Seung Hwan Shin, Myung-Jae Hwang, HyoSug Choi, Sara Na, Sangshin Park, Jue Seong Lee, Young June Choe, Yoonsun Yoon, Kyoungsan Seo, Jong Hee Kim, Hyun Mi Kang","doi":"10.3346/jkms.2024.39.e317","DOIUrl":"10.3346/jkms.2024.39.e317","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate the epidemiological characteristics and outcomes of myocarditis/pericarditis after BNT162b2 vaccination in Korean adolescents.</p><p><strong>Methods: </strong>This was a retrospective cohort analysis of adolescents aged 12-19 years old diagnosed with myocarditis/pericarditis within 42 days of BNT162b2 mRNA vaccination. All reported cases were investigated by city or government epidemiologists and the diagnostic certainty and causality was determined by the Korea Disease Control and Prevention Agency's Adverse Event Following Immunization Expert Advisory Committee according to the modified version of Brighton Collaboration Myocarditis/Pericarditis Working group's case definitions.</p><p><strong>Results: </strong>A total 3,709,063 adolescents aged 12-19 received 8,135,240 doses of the BNT162b2 vaccine in South Korea, and 184 cases met the Brighton criteria for the case definition of myocarditis and pericarditis with diagnostic certainty of possible and above. The median age was 17 years old (interquartile range [IQR], 15-18) and boys accounted for 81.5% (n = 150/184) of the cases. The overall incidence was 2.25 (95% confidence interval [CI], 1.94-2.60) cases per 100,000 doses and severe cases was 0.25 (95% CI, 0.15-3.80) cases per 100,000 doses. The highest incidence rate was observed in boys after the second dose, with 5.01 (95% CI, 4.12-6.17) cases per 100,000 doses. A total 89.1% (164/184) were classified as mild, and no deaths were reported.</p><p><strong>Conclusion: </strong>The highest incidence of myocarditis/pericarditis after BNT162b2 immunization was observed in male adolescents after the second dose, with majority of the cases presenting with a mild clinical course and favorable outcome.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 49","pages":"e317"},"PeriodicalIF":3.0,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11666327/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142881845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing the Gaps in Malaria Treatment in Korea. 解决韩国疟疾治疗方面的差距。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-12-23 DOI: 10.3346/jkms.2024.39.e331
Kyungmin Huh
{"title":"Addressing the Gaps in Malaria Treatment in Korea.","authors":"Kyungmin Huh","doi":"10.3346/jkms.2024.39.e331","DOIUrl":"10.3346/jkms.2024.39.e331","url":null,"abstract":"","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 49","pages":"e331"},"PeriodicalIF":3.0,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11666325/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142881825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of Pediatric Ulcerative Colitis at Diagnosis in Korea: Results From a Multicenter, Registry-Based, Inception Cohort Study. 韩国儿童溃疡性结肠炎的诊断特点:来自多中心、基于登记的初始队列研究的结果。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-12-23 DOI: 10.3346/jkms.2024.39.e303
Jin Gyu Lim, Ben Kang, Seak Hee Oh, Eell Ryoo, Yu Bin Kim, Yon Ho Choe, Yeoun Joo Lee, Minsoo Shin, Hye Ran Yang, Soon Chul Kim, Yoo Min Lee, Hong Koh, Ji Sook Park, So Yoon Choi, Su Jin Jeong, Yoon Lee, Ju Young Chang, Tae Hyeong Kim, Jung Ok Shim, Jin Soo Moon

Background: We aimed to investigate the characteristics of pediatric ulcerative colitis (UC) at diagnosis in Korea.

Methods: This was a multicenter, registry-based, inception cohort study conducted in Korea between 2021 and 2023. Children and adolescents newly diagnosed with UC < 18 years were included. Baseline clinicodemographics, results from laboratory, endoscopic exams, and Paris classification factors were collected, and associations between factors at diagnosis were investigated.

Results: A total 205 patients with UC were included. Male-to-female ratio was 1.59:1, and the median age at diagnosis was 14.7 years (interquartile range 11.9-16.2). Disease extent of E1 comprised 12.2% (25/205), E2 24.9% (51/205), E3 11.2% (23/205), and E4 51.7% (106/205) of the patients. S1 comprised 13.7% (28/205) of the patients. The proportion of patients with a disease severity of S1 was significantly higher in patients with E4 compared to the other groups (E1: 0% vs. E2: 2% vs. E3: 0% vs. E4: 24.5%, P < 0.001). Significant differences between disease extent groups were also observed in Pediatric Ulcerative Colitis Activity Index (median 25 vs. 35 vs. 40 vs. 45, respectively, P < 0.001), hemoglobin (median 13.5 vs. 13.2 vs. 11.6 vs. 11.4 g/dL, respectively, P < 0.001), platelet count (median 301 vs. 324 vs. 372 vs. 377 × 10³/μL, respectively, P = 0.001), C-reactive protein (median 0.05 vs. 0.10 vs. 0.17 vs. 0.38 mg/dL, respectively, P < 0.001), and Ulcerative Colitis Endoscopic Index of Severity (median 4 vs. 4 vs. 4 vs. 5, respectively, P = 0.006). No significant differences were observed in factors between groups divided according to sex and diagnosis age.

Conclusion: This study represents the largest multicenter pediatric inflammatory bowel disease cohort in Korea. Disease severity was associated with disease extent in pediatric patients with UC at diagnosis.

Trial registration: Clinical Research Information Service Identifier: KCT0008723.

背景:我们旨在调查韩国儿童溃疡性结肠炎(UC)的诊断特点。方法:这是一项多中心、基于注册的初始队列研究,于2021年至2023年在韩国进行。包括新诊断为UC < 18岁的儿童和青少年。收集基线临床人口学、实验室结果、内窥镜检查和Paris分类因素,并调查诊断时各因素之间的相关性。结果:共纳入205例UC患者。男女比例为1.59:1,诊断时中位年龄为14.7岁(四分位数间距11.9 ~ 16.2)。E1型占12.2% (25/205),E2型占24.9% (51/205),E3型占11.2% (23/205),E4型占51.7%(106/205)。S1占13.7%(28/205)。E4患者中S1严重程度的患者比例明显高于其他组(E1: 0% vs E2: 2% vs E3: 0% vs E4: 24.5%, P < 0.001)。小儿溃疡性结肠炎活动指数(中位数分别为25、35、40、45,P < 0.001)、血红蛋白(中位数分别为13.5、13.2、11.6、11.4 g/dL, P < 0.001)、血小板计数(中位数分别为301、324、372、377 × 10³/μL, P = 0.001)、c反应蛋白(中位数分别为0.05、0.10、0.17、0.38 mg/dL, P < 0.001)、溃疡性结肠炎内镜下严重程度指数(中位数分别为4比4比4比4比5,P = 0.006)。按性别和诊断年龄分组的各因素无显著差异。结论:本研究是韩国最大的多中心儿童炎症性肠病队列研究。在诊断为UC的儿童患者中,疾病严重程度与疾病程度相关。试验注册:临床研究信息服务标识:KCT0008723。
{"title":"Characteristics of Pediatric Ulcerative Colitis at Diagnosis in Korea: Results From a Multicenter, Registry-Based, Inception Cohort Study.","authors":"Jin Gyu Lim, Ben Kang, Seak Hee Oh, Eell Ryoo, Yu Bin Kim, Yon Ho Choe, Yeoun Joo Lee, Minsoo Shin, Hye Ran Yang, Soon Chul Kim, Yoo Min Lee, Hong Koh, Ji Sook Park, So Yoon Choi, Su Jin Jeong, Yoon Lee, Ju Young Chang, Tae Hyeong Kim, Jung Ok Shim, Jin Soo Moon","doi":"10.3346/jkms.2024.39.e303","DOIUrl":"10.3346/jkms.2024.39.e303","url":null,"abstract":"<p><strong>Background: </strong>We aimed to investigate the characteristics of pediatric ulcerative colitis (UC) at diagnosis in Korea.</p><p><strong>Methods: </strong>This was a multicenter, registry-based, inception cohort study conducted in Korea between 2021 and 2023. Children and adolescents newly diagnosed with UC < 18 years were included. Baseline clinicodemographics, results from laboratory, endoscopic exams, and Paris classification factors were collected, and associations between factors at diagnosis were investigated.</p><p><strong>Results: </strong>A total 205 patients with UC were included. Male-to-female ratio was 1.59:1, and the median age at diagnosis was 14.7 years (interquartile range 11.9-16.2). Disease extent of E1 comprised 12.2% (25/205), E2 24.9% (51/205), E3 11.2% (23/205), and E4 51.7% (106/205) of the patients. S1 comprised 13.7% (28/205) of the patients. The proportion of patients with a disease severity of S1 was significantly higher in patients with E4 compared to the other groups (E1: 0% vs. E2: 2% vs. E3: 0% vs. E4: 24.5%, <i>P</i> < 0.001). Significant differences between disease extent groups were also observed in Pediatric Ulcerative Colitis Activity Index (median 25 vs. 35 vs. 40 vs. 45, respectively, <i>P</i> < 0.001), hemoglobin (median 13.5 vs. 13.2 vs. 11.6 vs. 11.4 g/dL, respectively, <i>P</i> < 0.001), platelet count (median 301 vs. 324 vs. 372 vs. 377 × 10³/μL, respectively, <i>P</i> = 0.001), C-reactive protein (median 0.05 vs. 0.10 vs. 0.17 vs. 0.38 mg/dL, respectively, <i>P</i> < 0.001), and Ulcerative Colitis Endoscopic Index of Severity (median 4 vs. 4 vs. 4 vs. 5, respectively, <i>P</i> = 0.006). No significant differences were observed in factors between groups divided according to sex and diagnosis age.</p><p><strong>Conclusion: </strong>This study represents the largest multicenter pediatric inflammatory bowel disease cohort in Korea. Disease severity was associated with disease extent in pediatric patients with UC at diagnosis.</p><p><strong>Trial registration: </strong>Clinical Research Information Service Identifier: KCT0008723.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"39 49","pages":"e303"},"PeriodicalIF":3.0,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11666324/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142881841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Korean Medical Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1